Solving the 1907-FAT complex by X-ray co-crystallography To better understand the molecular basis of the FAT-1907 interaction, we co-crystallized and solved the FAT-1907 structure at 1.95 resolution (PDB 6PW8, Fig
Moving forward, the research community should prioritize properly designed human clinical trials examining BPC-157 in conditions with strong preclinical evidence and unmet clinical needs
That period where we need help, we need to be in a nursing home, where we cannot see, where were blind, we lose our other senses, we cannot walk, and if we can squeeze that period of our lives down into just a few months, spend the rest of the time productive and healthy, this is the world that I think we should strive for, and I think its doable, and its very personal
Conservative starting doses would be essential: Initial phase : Cagrilintide 0.3 mg + Tirzepatide 2.5 mg weekly Escalation : Increase cagrilintide by 0.3-0.6 mg every 4 weeks Tirzepatide adjustment : Maintain or modestly increase based on tolerance Monitoring : Close observation for cumulative GI effects This remains speculative, as no published trials have examined this specific combination
We love that these come in a wide array of colors (Candy Heart Pink, anyone?)